| |
|
|
|
Infinity Pharmaceuti
|
|
2.70 -0.25 (-8.47%) |
10/17/2017 4:00pm |
|
Open: |
2.95 |
Pre close: |
2.95 |
Target:
|
4.38
|
|
High: |
3.07 |
Low: |
2.68 |
Resistance:
|
3.75
4.38
|
|
Volume: |
2,152,105 |
Market Cap: |
136.86M |
Support:
|
2.11
1.10
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.79
 |
MACD |
MACD(12,26):
|
0.42 |
|
MA(20): |
1.66 |
Signal(12,26,9): |
0.24 |
|
MA(100): |
1.46 |
Stochastic Oscillator |
%K(14,3):
|
65.73  |
|
MA(250): |
1.76 |
%D(3): |
77.47 |
|
Average Volume(K) |
3-Month: |
202093
|
52-Week |
High:
|
3.84 |
|
10-Days: |
735752 |
Low: |
0.84 |
|
RSI |
RSI(14):
|
64.87 |
Change(%): |
100.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.390 |
Return on Equity (ttm) |
-78.6 |
Shares Out. (M) |
0.00 |
|
EPS Est. Current Year |
-0.920 |
Return on Assets (ttm) |
-26.6 |
Shares Float (M) |
38.33 |
|
EPS Est. Next Year |
-1.500 |
PEG Ratio |
-0.05 |
% Held by Insiders |
2.57 |
|
EPS Est. Next Quarter |
-0.200 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
72.41 |
|
Forward EPS |
-1.494 |
Gross Profit (p.s.) |
0.369 |
Shares Short (K) |
1390 |
|
Book Value (p.s.) |
1.170 |
EBITDA (p.s.) |
-1.099 |
P/E |
-1.94 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.31 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-82.94 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-49.17 |
P/CF |
-0.00 |
|
|
|
|
|
|
|
